NEURELIS, INC. v. AQUESTIVE THERAPEUTICS, INC.

No. D077984 No. D078186.

71 Cal.App.5th 769 (2021)

NEURELIS, INC., Plaintiff and Respondent, v. AQUESTIVE THERAPEUTICS, INC., Defendant and Appellant. NEURELIS, INC., Plaintiff and Appellant, v. AQUESTIVE THERAPEUTICS, INC., Defendant and Respondent.

Court of Appeals of California, Fourth District, Division One.

November 17, 2021.


Attorney(s) appearing for the Case

Latham & Watkins, John T. Ryan , David F. Kowalski and Nicole C. Valco for Plaintiff and Appellant.

Steptoe & Johnson, Jason Levin , Melanie A. Ayerh and Jamie L. Lucia for Defendant and Appellant and for Defendant and Respondent.

Latham & Watkins, John T. Ryan , David F. Kowalski , Nicole C. Valco , Amit Makker , Melissa Arbus Sherry and Shannon Grammel for Plaintiff and Respondent.


OPINION

Neurelis, Inc. (Neurelis), and Aquestive Therapeutics, Inc. (Aquestive), are pharmaceutical companies developing their own respective means to administer diazepam, a drug used to treat acute repetitive seizures (ARS). Neurelis was further along in the development...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases